Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details)

v3.25.2
Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Accrued and other liabilities    
Accrued short-term interest payable $ 2,914 $ 3,039
Accrued incentive compensation 790 1,555
Accrued clinical liabilities   306
Income taxes payable in connection with Pulmokine acquisition   280
Accrued legal and accounting fees 719 251
Accrued termination benefits 281  
Accrued payroll and benefits 131 170
Other accrued liabilities 576 151
Total $ 5,411 $ 5,752